Wednesday, June 13, 2018

Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSXV: $N.V, TSXV: $KHRN.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $ICC.V


Investor Ideas #Potcasts; #Cannabis News and Stocks on the Move; TSXV: $N.V, TSXV: $KHRN.V, TSX: $TRST.TO, TSX: $ACB.TO, TSXV: $ICC.V




Pt. Roberts, WA; Delta, BC –June 13, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its “potcast’ site, www.potcasts.ca  release today’s edition of
its new series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:


Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast; looking at cannabis news, stocks to watch as well as insights from thought leaders and experts. Today we have news announcements from Namaste Technologies Inc. (TSX-: N), Khiron Life Sciences Corp. (TSX-V: KHRN) , CannTrust Holdings Inc ( TSX: TRST) , Aurora Cannabis Inc. (TSX: ACB , OTCQB : ACBFF ) and ICC Labs Inc. (TSX-V:  ICC).

Namaste Technologies Inc. announced that further to its April 25th, 2018 announcement of a Letter of Intent with Pineapple Express Delivery Inc., the Company has signed a Subscription Agreement to acquire 15% of the share capital of Pineapple Express Delivery Inc. for  $1,000,000. Additionally, Namaste is pleased to announce that Pineapple Express Delivery Inc. has secured a Courier Services Agreement with Ample Organics, Canada's leading seed-to-sale software platform, for same-day cannabis delivery. Both transactions validate Namaste's position as a leader in cannabis focused technology platforms, and further demonstrate Namaste's ability to identify these value-added services aimed at enhancing the user experience. Namaste is optimistic about its equity investment in Pineapple Express Delivery Inc. and expects to see an immediate impact to the overall business operation.

Khiron Life Sciences Corp., a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that the Company has been registered by the Colombian Agricultural Institute ("ICA") as an agronomical unit. Khiron is one of two companies in Colombia to receive this registration.

As a mandatory requirement for commercializing medical cannabis products in Colombia for distribution, this milestone positions Khiron to receive the first allocation of quota to commence commercial cultivation of high THC strains, and to commence commercial cultivation and production of CBD strains which do not require quota.

CannTrust Holdings Inc., one of Canada's leading licensed producers of medical cannabis, announced the signing of an agreement with Kwantlen Polytechnic University (KPU) to collaborate on the ongoing development of the university's non-academic Cannabis Career Training program.

CannTrust, in partnership with KPU, will assist in the continued development of the Cannabis Career Training program, with the aim of providing students with the necessary work skills required for the industry's continually evolving demands. Delivered in an online format, the program is easily accessible and is in extremely high demand all across Canada.

Aurora Cannabis Inc. announced today that it intends to complete a $7 million investment in Choom Holdings Inc., trading on the CSE as CHOO, whereby Aurora will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share, representing an 8% ownership interest.

Choom currently operates two late stage applicants under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). Choom has agreements in place to acquire two additional late-stage applicant craft growers in BC and Saskatchewan, including a facility in Sooke, British Columbia, anticipated to receive its cultivation license from Health Canada in the third quarter of 2018.


ICC Labs Inc. announced that KSK Labs, a 100% subsidiary of Global Group Kalapa, of which ICC Labs recently acquired 25%, subject to TSX Venture Exchange approval, has closed a presale agreement with a Spain-based company, VenPharma, in order to distribute cannabidiol (“CBD”) products in Spanish pharmacies and drugstores.

VenPharma is a laboratory specialized in natural medicine since its foundation in 1976, with more than 1,300 points of sales in Spain. The agreed first order is of 140,000 CBD products between sublingual CBD oils of 2% and 10%, CBD creams and infusions based on hemp, to be distributed through 500 point of sales. The intention with the next orders is to sell over than 370,000 CBD products annually through all the 1,300 points of sales.


Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   



Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: http://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Google Play Music, Stitcher and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Ideas
Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  
Investorideas.com cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: http://www.investorideas.com/About/Private_Policy.asp

To sponsor this podcast or be a guest

Contact Investorideas.com

800-665-0411




Marijuana / Hemp Stocks at Cannabisinvestorideas.com and Investorideas.com

Like Marijuana / Hemp Stocks? View our Marijuana / Hemp Stocks Directory
Also check out our AI blog Global Cannabis Investing - features Investor Ideas Cannabis news


No comments:

Post a Comment